Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome
about
Lack of autoantibody production associated with cytomegalovirus infectionA processive lipid glycosyltransferase in the small human pathogen Mycoplasma pneumoniae: involvement in host immune responseIncreased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease.Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system.Ganglioside mimicry and peripheral nerve disease.Guillain-Barré syndrome following hepatitis E.Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study.Recent developments and future directions in Guillain-Barré syndrome.Mycoplasma pneumoniae triggering the Guillain-Barré syndrome: A case-control study.Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation.Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.Case report: Hepatitis A preceding Guillain-Barré syndrome.Role of gancyclovir and HAART administration in the treatment of a rare complication of HIV disease: cytomegalovirus-associated Guillain-Barré syndrome.A Guillain-Barré syndrome variant with prominent facial diplegia.Insights into the Structural Basis of Antibody Affinity Maturation from Next-Generation Sequencing.Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome.
P2860
Q24801045-F2AAB329-B629-443A-9CB2-B06A31E528E7Q28484726-9566E1DC-C5B6-4060-98B8-D945699251C5Q35554016-69C46E39-125F-40E1-BE80-E56B17C21CF6Q35842193-617C92AB-79BC-4268-991D-D1459855AAE7Q36764831-72A8ED3C-15C0-4CC7-A1B4-56A254B1802CQ37160576-13C33635-0EC0-4F89-BDD6-7A59F93FD89AQ37862292-F21A8647-A420-40DB-A352-84A09C1F58B2Q38070887-5CD009D4-D45F-4AA6-B5FD-5E007218E4E2Q40588856-CFE661C2-85D4-444A-A50B-6BED94E76D0FQ40779366-147AA741-7F11-4020-B86C-2843491185FFQ40862168-A79A975D-5A8F-4957-A39E-A339BE0D20B8Q43766565-0004AC75-442E-486D-9EC1-16F1577CB5F7Q43836008-863374CB-5000-439A-B1EE-906EC4753B65Q45360740-02D858FA-2F9D-448A-85D9-55490967BAD5Q49956907-894EBB6B-5CEF-4357-9CDD-FE51D49D2E21Q55519293-F821311A-678F-4E95-938E-A96A185FB1FD
P2860
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@ast
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@en
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@nl
type
label
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@ast
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@en
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@nl
prefLabel
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@ast
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@en
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@nl
P2093
P356
P1433
P1476
Cross-reactive antibodies agai ...... sts in Guillain-Barré syndrome
@en
P2093
A D Osterhaus
A H Brandenburg
B C Jacobs
F G van der Meché
P A van Doorn
P304
P356
10.1212/WNL.54.7.1453
P407
P577
2000-04-11T00:00:00Z